We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03816163
Brief Title: A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

First Submitted : January 23, 2019
First Submitted that Met QC Criteria : January 23, 2019
First Posted : January 25, 2019

Last Update Submitted that Met QC Criteria : January 13, 2023
Last Update Posted : January 17, 2023